Skip to Content

Tag: Kevin Sayer

Kevin Sayer

Specialty Providers

Dexcom exec: CGM is ‘undisputed standard of care’

January 13, 2023Tracy Orzel

SAN DIEGO – Dexcom’s next-generation G7 continuous glucose monitoring (CGM) system will empower users to take control of their health, says top company exec Kevin Sayer.  Dexcom in December received clearance from the U.S. Food and Drug Administration for the device, which can be used for people with all types of diabetes ages two years and older.  “The FDA approval of Dexcom G7 is a huge milestone for the diabetes community and underscores continued momentum in...

Continuous Glucose Monitor (CGM), Dexcom, Dexcom G7, Diabetes, Kevin Sayer

Read Full Articlered right arrow icon